The extended system is suitable for open, MIS and cement-augmented techniques while providing additional options to stabilize the upper-thoracic spine.
DiscGenics announced positive two-year clinical data from its study of discogenic progenitor cell therapy in the treatment of degenerative disc disease.
Heraeus Medical’s PALACOS bone cements containing antibiotic have received Medical Device Regulation (MDR) approval. These include the products PALACOS R+G,...